Universität Wien FIND

Due to the COVID-19 pandemic, changes to courses and exams may be necessary at short notice. Inform yourself about the current status on u:find and check your e-mails regularly. Registration is mandatory for courses and exams. Wearing a FFP2 face mask and a valid evidence of being tested, vaccinated or have recovered from an infection are mandatory on site.

Please read the information on studieren.univie.ac.at/en/info.

322056 VO Introduction to Nanomedicine: Nucleic acid therapy and Bioimaging - M14 (2020W)

1.00 ECTS (1.00 SWS), SPL 32 - Pharmazie


Note: The time of your registration within the registration period has no effect on the allocation of places (no first come, first served).


Language: English

Examination dates



The lectures will be held in a digital format (on-line) via Moodle by using the 'Collaborate' tool.

All uploaded information/documents (e.g. files, data, etc.) are solely to be used for personal use of the course participant.
Owing to copyright rules and regulations, sharing or uploading of the above to any other platform or social platforms is strictly forbidden.

The schedule for on-line lectures is as follows-
Timeslot: 10:30-12:00
Dates: 9.12.2020, 15.12.2020, 17.12.2020, 12.1.2021, 14.1.2021, 19.1.2021, 20.1.2021, 21.1.2021.

Please email to haider.sami@univie.ac.at for enrolment into Moodle course.


Aims, contents and method of the course

This is an introductory course on nanomedicine, with special focus on nucleic acid therapy and bioimaging. Nanomedicine is an upcoming field which is impacting health sciences significantly by developing new nano-pharmaceuticals and investigating the associated challenges.

The course will cover the following topics:-
Introduction to nanotechnology, nanomaterials and nanoscale (within the context of biotechnology and biopharmaceutics)- basic concepts and definitions.

Introduction to nanomedicine (within the general context of biomedical applications and with special focus on nucleic acid therapy and bioimaging)- general concepts, definitions, claims and scope, pharmaceutical and biomedical applications, changing landscape of pharmaceuticals containing nanomaterials, nanomedicine/nanomaterial platforms for nucleic acid therapy and bioimaging applications, selected examples of nanomedicine platforms under pre-clinical trials/clinical trials/clinical use, biological challenges faced by nanomedicines, physicochemical and biological characterization techniques for relevant nanopharmaceutics.

Assessment and permitted materials

Examination at the end of the course.

Minimum requirements and assessment criteria

Attending all the lectures, active participation in the course and performance in the examination.

Examination topics

Topics covered in the lectures.

Reading list

All required reading materials will be uploaded on the Moodle link of the course.

Association in the course directory

MA23, A400

Last modified: We 03.02.2021 10:51